halofuginone

transforming growth factor beta 1 ; Homo sapiens







14 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33433355 Halofuginone regulates keloid fibroblast fibrotic response to TGF-β induction. 2021 Mar 1
2 29156807 Halofuginone inhibits TGF-β/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. 2017 Oct 17 4
3 27687492 Single-cell analysis reveals IGF-1 potentiation of inhibition of the TGF-β/Smad pathway of fibrosis in human keratocytes in vitro. 2016 Sep 30 1
4 26015407 Anticancer activity of halofuginone in a preclinical model of osteosarcoma: inhibition of tumor growth and lung metastases. 2015 Jun 10 3
5 23845969 Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts. 2014 Apr 1
6 25356039 Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract. 2014 Oct 28 1
7 22393274 Halofuginone down-regulates Smad3 expression and inhibits the TGFbeta-induced expression of fibrotic markers in human corneal fibroblasts. 2012 4
8 23002206 Halofuginone inhibits the establishment and progression of melanoma bone metastases. 2012 Dec 1 2
9 21117034 Halofuginone and muscular dystrophy. 2011 Jan 1
10 19713035 Halofuginone enhances the radiation sensitivity of human tumor cell lines. 2010 Mar 1 2
11 17180598 Gene expression during chemically induced liver fibrosis: effect of halofuginone on TGF-beta signaling. 2007 Apr 3
12 16769768 Halofuginone inhibits NF-kappaB and p38 MAPK in activated T cells. 2006 Aug 3
13 14732719 Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. 2004 Apr 9 1
14 12869955 Halofuginone to treat fibrosis in chronic graft-versus-host disease and scleroderma. 2003 Jul 1